Nucleus RadioPharma Raises $56 Million To Advance Radiopharmaceutical Technology
By Dan Anderson ● Oct 24, 2023
Nucleus RadioPharma - the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals - recently announced an oversubscribed $56 million Series A funding round led by Eclipse and GE HealthCare with participation from Echo Global, Fox Chase Cancer Center, Granger Management, Mayo Clinic, Mercy Health, and the University of Missouri. With this funding round, Nucleus RadioPharma will establish multiple new manufacturing facilities nationwide, including Rochester, Minnesota, near the Mayo Clinic, and build novel technology for developing, manufacturing, and distributing radiopharmaceuticals.